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Systolic and Diastolic Dyssynchrony in Patients With
Diastolic Heart Failure and the Effect of Medical Therapy
Jianwen Wang, MD, PHD, Karla M. Kurrelmeyer, MD, Guillermo Torre-Amione, MD, PHD,
Sherif F. Nagueh, MD
Houston, Texas
Objectives The purpose of this study was to determine the prevalence of systolic and diastolic dyssynchrony in diastolic
heart failure (DHF) patients and identify the effects of medical therapy.
Background The prevalence of systolic and diastolic dyssynchrony in DHF patients is unknown with no data on the effects of
medical therapy on dyssynchrony.
Methods Patients presenting with DHF (n  60; 61  9 years old, 35 women) underwent echocardiographic imaging si-
multaneous with invasive measurements. An age-matched control group of 35 subjects and 60 patients with
systolic heart failure (SHF) were included for comparison. Systolic and diastolic dyssynchrony were assessed by
tissue Doppler and defined using mean and SD values in the control group.
Results Systolic dyssynchrony was present in 20 patients (33%) with DHF and 24 patients (40%) with SHF and was asso-
ciated in both groups with significantly worse left ventricular (LV) systolic and diastolic properties (p  0.05 vs.
control group and patients without systolic dyssynchrony). Diastolic dyssynchrony was present in 35 patients
(58%) with DHF and 36 patients (60%) with SHF and had significant inverse correlations with mean wedge pres-
sure and time constant of LV relaxation. In DHF patients, medical therapy resulted in significant shortening of
diastolic time delay (39  23 ms to 28  20 ms; p  0.02) but no significant change in systolic interval (p 
0.15). Shortening of diastolic time delay correlated well with  shortening after therapy (r  0.85; p  0.001).
Conclusions Systolic dyssynchrony occurs in 33% of DHF patients, and diastolic dyssynchrony occurs in 58%. Medical therapy re-
sults in significant shortening of the diastolic intraventricular time delay which is closely related to improvement in LV
relaxation. (J Am Coll Cardiol 2007;49:88–96) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.023E
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dystolic dyssynchrony in patients with congestive heart
ailure and depressed ejection fraction (EF) is associated
ith increased morbidity and mortality, even when it occurs
n the presence of a normal QRS duration (1). Treatment of
yssynchrony by atrial synchronized biventricular pacing
See page 106
eads to an improvement in left ventricular (LV) function
nd symptomatic status (2). The presence of mechanical
yssynchrony in patients with normal EF has not been
irectly examined, but there have been 2 published studies
hat are relevant to this topic. In the first report, the
resence of dyssynchrony in patients with congestive heart
ailure and EF 40% was investigated. That study showed
hat systolic dyssynchrony is not uncommon in patients with
rom the Department of Cardiology and Methodist DeBakey Heart Center, The
ethodist Hospital, Houston, Texas.a
Manuscript received June 8, 2006; revised manuscript received July 25, 2006,
ccepted August 14, 2006.F 40% (3). In the second study, the presence of a
rolonged QRS duration was associated with worse out-
ome in patients with congestive heart failure and normal
F (4). However, those 2 studies are limited in their
onclusions, as they pertain to congestive heart failure
atients with normal EF: one study included patients with
epressed EF and the other used QRS duration as a
urrogate for mechanical dyssynchrony (3,4). Therefore, the
opic of systolic and diastolic dyssynchrony in patients with
ongestive heart failure and normal EF remains to be
irectly addressed, including the impact of mechanical
yssynchrony on cardiac systolic and diastolic function in
his population.
In addition, it is important to identify safe and effective
herapeutic measures for this abnormality in patients with
iastolic heart failure, given the high prevalence as well as
he morbidity and mortality of this disease (5). In that
egard, there are few studies that have examined the effects
f medical and nonmedical treatment in patients with
iastolic dysfunction and normal EF. Those studies evalu-
ted patients with coronary artery disease (6), aortic stenosis
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January 2/9, 2007:88–96 Dyssynchrony in DHF7), and hypertrophic cardiomyopathy (8,9), but to our
nowledge none examined patients with isolated diastolic
eart failure (DHF). We hypothesized that both systolic
nd diastolic dyssynchrony occur in this population, possibly
elated to conduction system disease, myocardial pathology
f hypertrophy and fibrosis, abnormal coronary flow reserve
elated to hypertrophy, and increased afterload. Therefore,
reatment aimed at each of the above targets may improve
yssynchrony, cardiac function, and symptomatic status. In
hat regard, medical therapy that decreases afterload, im-
roves myocardial blood flow, and reduces interstitial fibro-
is may be effective. We therefore undertook this study to
xamine the prevalence of dyssynchrony in patients present-
ng with DHF as well as the effects of medical therapy on
his abnormality.
ethods
atient population. Consecutive patients with the clinical
iagnosis of congestive heart failure by the Framingham
riteria (10) who were already scheduled for cardiac cathe-
erization underwent transthoracic echocardiographic imag-
ng simultaneous with invasive measurements. All patients
ad an EF50% by 2-dimensional (2D) echocardiography.
atients with atrial fibrillation (n  10; these patients were
xcluded from the study to avoid the confounding effect of
ariation in RR cycle length in computing timing intervals),
ore than mild valvular stenosis or regurgitation, and/or
nadequate echocardiographic images (n  5) were ex-
luded. In addition to the clinical status and EF, diastolic
ysfunction and DHF were diagnosed if mean pulmonary
apillary wedge pressure (PCWP) was 12 mm Hg and/or
he time constant of LV relaxation () was 48 ms (11).
ixty patients were enrolled in this study. There were 40
atients (66%) with hypertension, 15 (25%) with diabetes
ellitus, and 8 (13%) with coronary artery disease. None of
he patients had wall motion abnormalities on 2D
chocardiography.
In addition, we included 2 other groups for comparison:
group of 35 normal subjects, who were age and gender
atched to patients with DHF, and 60 patients with
ystolic heart failure (SHF) with EF 50%. Subjects in the
ontrol group were referred to the echocardiographic labo-
atory for evaluation of a cardiac murmur and had a normal
chocardiogram and no history of cardiovascular disease. All
easurements of LV systolic and diastolic function were
lso normal. The control group was identified a priori and
as not selected based on any of the measurements in the
eart failure groups.
Patients with SHF were age and gender matched to the
HF group and likewise had simultaneous hemodynamic
nd echocardiographic measurements.
chocardiographic studies. All of the examination proce-
ures were carried out to provide a comprehensive echocar-
iographic examination that would enable assessment of LV
ystolic and diastolic function using several indices. Two- cimensional images were ac-
uired in the parasternal views.
pical views were acquired, and
ulse-Doppler was used to
ecord transmitral and pulmo-
ary venous flow in the apical
-chamber view (12). Tissue
oppler (TD) was applied to
ecord myocardial velocities at
he septal, lateral, anterior, and
nferior walls, with adjustment of
epth and sector width to
chieve frame rates of 100
rames/s. Echocardiographic im-
ges were stored digitally and
nalyzed offline.
chocardiographic analysis.
he analysis was performed off-
ine without knowledge of clinical status. LV volumes, mass,
F, and left atrium (LA) maximum volume were measured
er American Society of Echocardiography recommenda-
ions (13). Stroke volume was derived as the difference
etween end-diastolic (EDV) and end-systolic (ESV) vol-
mes. End-systolic pressure (ESP) was derived as: 0.9 
ystolic blood pressure (14). Mid-wall fractional shortening
as computed (15), and its relation to end-systolic circum-
erential wall stress (16) was evaluated.
All Doppler measurements represent the average of 3
eats. Mitral inflow was analyzed for peak E (early diastolic)
elocity, peak A (late diastolic) velocity, E/A ratio, and
eceleration time (DT) of E velocity. Pulmonary artery
ystolic pressure was calculated using the tricuspid regurgi-
ation jet and right atrial pressure estimation using inferior
ena cava diameter and respiratory collapse in addition to
epatic venous flow (12). From the pulmonary vein flow
ignals, the velocity, time velocity integral, and duration of
eak systolic, diastolic, and atrial flows were determined.
he systolic (Sa) and early diastolic (Ea) velocities at the
eptal and lateral areas of the mitral annulus were measured
12).
For the control group, noninvasive estimates of mean
edge pressure (12) and  (see the following text and
eference 19) were used.
ssessment of systolic and diastolic dyssynchrony. Onset
17) and peak (18) of systolic velocity and onset of early
iastolic velocity (17) in the TD signal were timed using the
RS complex as the reference point. The average of 3
onsecutive beats was calculated. Intraventricular systolic
yssynchrony was defined using the time difference between
he shortest and longest delay between the QRS complex
nd onset/peak of systolic velocity among the 4 LV walls
intraobserver mean difference  3  3 ms; interobserver
ean difference  6  3 ms). Likewise, intraventricular
iastolic dyssynchrony was defined using the time difference
etween the shortest and longest delays between the QRS
Abbreviations
and Acronyms
DHF  diastolic heart
failure
EF  ejection fraction
ESP  end-systolic
pressure
ESV  end-systolic volume
LA  left atrial
LV  left ventricular
PCWP  pulmonary
capillary wedge pressure
SHF  systolic heart failure
SW  stroke work
TD  tissue Doppleromplex and onset of early diastolic velocity among the 4
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Dyssynchrony in DHF January 2/9, 2007:88–96V walls (intraobserver mean difference  4  3 ms;
nterobserver mean difference  5  3 ms).
ight heart catheterization. Medex transducers were bal-
nced before acquisition of hemodynamic data, with the
ero level at the mid-axillary line. Pressure measurements
ere acquired at end-expiration and represent the average of
cardiac cycles. The position of the PA catheter was
erified by fluoroscopy, and pulmonary capillary wedge
ressure (PCWP) was determined using changes in pressure
aveform and, when needed, O2 saturation. Cardiac output
as derived by thermodilution, where 3 cardiac cycles with
10% variation were averaged. The time constant of LV
elaxation () was computed using the previously validated
quation   IVRT/(Ln ESP  Ln PCWP) (19), where
VRT is isovolumetric relaxation time as measured by
oppler, and PCWP was obtained by invasive measure-
ents. In addition,  was calculated using the noninvasive
stimation of mean PCWP (12) at baseline and follow-up.
ssessment of LV systolic properties. The LV systolic
roperties were examined as reported in a recent study (20).
he LV systolic performance was assessed using stroke
ork (SW), calculated as the product of stroke volume and
ean arterial pressure. The LV systolic function was exam-
ned using EF and the relationship between SW and LV
nd-diastolic volume. The ratio of ESP to ESV was used an
ndex of LV contractility (21). The relation between mid-
all fractional shortening and circumferential wall stress
as used to gain insight into myocardial contractility.
tatistics. Demographic and echocardiographic variables
ere compared between the control group and patients with
HF and DHF using analysis of variance with the Holm-
idak method for pairwise comparisons. This methodology
as used to compare the 3 groups of SHF and DHF (see
ubsequent). Changes in hemodynamic and echocardio-
raphic measurements with medical therapy were compared
ith paired t tests. Linear regression analysis was used to
Clinical and Echocardiographic Summary of the
Table 1 Clinical and Echocardiographic Sum
Control (n 
Age (yrs) 60 11
Gender (M/F) 14/21
Heart rate 70 8
Blood pressure (mm Hg) 116 11/68
EF (%) 64 6
LV EDV (ml) 116 13
LV mass (gm/m2) 81 21
LA volume (ml/m2) 18 6*
Deceleration, time (ms) 213 38
Pulmonary veins (Ar-A) (ms) 1 10
E/Ea ratio (average) 5 3*
PA systolic pressure (mm Hg) 23 3*
Systolic intraventricular delay (ms) 12 10
Diastolic intraventricular delay (ms) 10 9*
*p  0.05 versus DHF and SHF groups; †p  0.05 versus control and
Ar-A  difference in duration between Ar velocity in pulmonary venous flow
end-diastolic volume; EF  ejection fraction; LA  left atrial; LV  left ventricelate hemodynamic and echocardiographic measurements
o Doppler indices of dyssynchrony. A p value of0.05 was
onsidered significant.
esults
atients with SHF and DHF were similar to the control
roup with respect to age and gender distribution. However,
HF and SHF patients had significantly higher LV mass,
A volume index, E/Ea ratio, and PA systolic pressure as
ell as a longer Ar duration in pulmonary venous flow and
shorter DT (Table 1). For time delay measurements by
D, significantly longer systolic and diastolic intraventric-
lar delays were noted in patients with SHF and DHF.
ardiac function in DHF patients with and without
yssynchrony. In the DHF group, there were 20 patients
33%) with systolic dyssynchrony (time delay 35 ms,
hich exceeds the mean  2 SD in the control group). The
ame patients were identified whether the time to onset or
he time to peak systolic velocity was used. Of the 20
atients with systolic dyssynchrony, 15 had a systolic intra-
entricular time delay of 60 ms. The QRS duration was
ignificantly longer in these 20 patients than in the remain-
ng 40 (118  25 vs. 93  30; p 0.05) but with a wide
verlap between the 2 groups. A weak correlation was
resent between the QRS duration and the systolic time
elay (r  0.33; p  0.04). The septum was the most
elayed region in 2 patients, the inferior wall in 3, the
nterior wall in 4, and the lateral wall in 11 (55%).
Several significant differences in LV systolic and diastolic
arameters were observed in DHF patients with systolic
yssynchrony. These patients had significantly lower SW
Fig. 1), EF, ESP/ESV ratio, SW/EDV ratio, mid-wall
ractional shortening (Fig. 2), and Sa velocity. Mean PCWP
as significantly higher, and  was significantly longer
Table 2).
ups: Control, SHF, and DHF
of the 3 Groups: Control, SHF, and DHF
SHF (n  60) DHF (n  60)
63 13 61 9
24/36 25/35
78 14 74 10
90 13/60 11‡ 145 28/86 19
30 6† 61 8
180 33† 110 35
138 31‡ 120 38
73 28 65 10
169 23 189 30
53 10 48 5
21 4 18 5
53 8 46 5
35 21 31 25
38 20 39 23
roup; ‡p  0.05 versus DHF group.3 Gro
mary
35)
 8*
*
*
*
*
DHF g
and A velocity in mitral inflow; DHF  diastolic heart failure; EDV 
ular; PA  pulmonary artery; SHF  systolic heart failure.
(
c
t
A
a
w
i
o
D
d
d
s
c
s
d
a
D

r
0
C
d
(
c
i
w
d
d
a
e
d
s
(
d
b
0
5
t
w
c
i
m
m
E
s
f
(
n
2
i
T
S
s
v
i
m
s
t
i

91JACC Vol. 49, No. 1, 2007 Wang et al.
January 2/9, 2007:88–96 Dyssynchrony in DHFThere were 35 patients (58%) with diastolic dyssynchrony
time delay 35 ms). The 20 patients with systolic dyssyn-
hrony had evidence of diastolic dyssynchrony. In addition,
here were 15 patients with isolated diastolic dyssynchrony.
weak correlation was present between the QRS duration
nd diastolic time delay (r  0.3; p  0.05). The septum
as the most delayed region in 3 patients, the inferior wall
n 6, the anterior wall in 8, and the lateral wall in 18 (51%).
In general, hemodynamic and echocardiographic indices
f LV systolic properties were similar between patients with
HF and no dyssynchrony and those with isolated diastolic
yssynchrony. Figure 3 shows the correlation between the
iastolic time delay and mean PCWP and . A strongly
ignificant correlation is present between diastolic dyssyn-
hrony and each of these 2 measurements. In addition,
everal significant correlations were noted between the
iastolic time delay and LV mass (Fig. 4) as well as Doppler
nd 2D measurements of LV diastolic function, including
T (r  0.63; p  0.01), Ar  A duration (r  0.61; p
0.01), LA volume (r  0.59; p  0.01), LV mass/EDV
atio (r  0.85; p  0.01), and E/Ea ratio (r  0.71; p 
.01).
ardiac function in SHF patients with and without
yssynchrony. In the SHF group, there were 24 patients
40%) with systolic dyssynchrony (definition based on the
ontrol group as in preceding), with 18 patients having an
ntraventricular time delay of 60 ms. A weak correlation
as present between the QRS duration and the systolic time
elay (r  0.34; p  0.035). The septum was the most
Figure 1 Relationship Between Left
Ventricular EDV and Stroke Work
The relationship in the control group is shown by the solid line and solid cir-
cles (r2  0.93; p  0.001). The relationship in patients with diastolic heart
failure (DHF) and systolic dyssynchrony (r2  0.94; p  0.001) is shown by the
dotted line and open circles. The relationship in patients with DHF but without
systolic dyssynchrony (r2  0.9; p  0.001) is shown by the dashed line and
solid squares. The DHF patients without systolic dyssynchrony and the control
group had similar linear relationships. This relationship was shifted downward
in patients with DHF and systolic dyssynchrony. EDV  end-diastolic volume.elayed region in 3 patients, the inferior wall in 5, thenterior wall in 5, and the lateral wall in 11 (46%). As
xpected, patients with SHF had abnormal LV systolic and
iastolic function (Table 3), with the worst function ob-
erved in the 24 patients with systolic dyssynchrony.
There were 36 patients (60%) with diastolic dyssynchrony
definition as in preceding), with 12 patients having isolated
iastolic dyssynchrony. A weak correlation was present
etween the QRS duration and the diastolic time delay (r
.36; p 0.03). The septum was the most delayed region in
patients, the inferior wall in 8, the anterior wall in 7, and
he lateral wall in 16 (44%). Overall, LV diastolic function
as worse in the patients with diastolic dyssynchrony
ompared with those without (Table 3). The diastolic
ntraventricular time delay was significantly related to LV
ass (r  0.59; p  0.01), EDV (r  0.6; p  0.01), and
ass/volume ratio (r  0.63; p  0.01).
ffect of medical therapy for DHF on LV function and
ystolic and diastolic dyssynchrony. Patients were treated
or DHF with intravenous diuretics (n  60), beta-blockers
n  15), calcium-channel blockers (verapamil or diltiazem;
 20), angiotensin-converting enzyme inhibitors (n 
5), and/or angiotensin-receptor blockers (n  10). Repeat
maging was performed 3 to 15 days after the initial studies.
able 4 shows a summary of the changes with therapy.
ystemic blood pressure decreased significantly, whereas no
ignificant change was noted in EF, LV mass, and LA
olume index in the overall group. Doppler measurements
ndicated a decrease in LV filling pressures and an improve-
ent in LV relaxation. A nonsignificant decrease in the
ystolic intraventricular time delay was noted (31  25 ms
o 28  21 ms; p  0.15). On the other hand, the diastolic
ntraventricular time delay became significantly shorter (39
23 ms to 28  20 ms; p  0.02).
Figure 2 Relationship Between Mid-Wall Fractional
Shortening and Circumferential Wall Stress
Patients with diastolic heart failure (DHF) and systolic dyssynchrony are shown
by open circles, whereas patients with DHF but without dyssynchrony are
shown by solid circles. The data points for patients with DHF and systolic
dyssnchrony were outside the lower 95% prediction interval for the control
group.
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Dyssynchrony in DHF January 2/9, 2007:88–96elation of the change in LV diastolic dyssynchrony to
V relaxation and filling. A significant positive correlation
as noted between the decrease in LV ESP and the
hortening in diastolic time delay (r  0.71; p  0.01). In
urn, the change in diastolic time delay correlated signifi-
antly with the shortening in  (r  0.85; p  0.001) (Fig.
), the increase in Ea velocity (r  0.75; p  0.01), and
he decrease in E/Ea ratio (r  0.8; p  0.01). On multiple
egression analysis, the decrease in ESP and the shortening
f the diastolic time delay were the main determinants of
he improvement in  (R2  0.84; p  0.01).
Figure 3 Relation Between LV Diastolic Intraventricular Time D
Relationship between maximum diastolic time delay and relaxation time constant
in patients with diastolic heart failure. LV  left ventricular; PCWP  pulmonary ca
emodynamic and Echocardiographic Measurements in DHF Patientratified Ac ording to Presence or Abs nce of Systolic and Diasto
Table 2 Hemodynamic and Echocardiographic Measurements inStratified According to Presence or Absence of Systoli
Control
(n  35)
DHF
D
Stroke work (kg · cm) 8.9 2.5
Ejection fraction (%) 64 6
Stroke work/EDV (g/cm2) 76 8
ESP/ESV (mm Hg/ml) 2.4 0.8
Mid-wall fractional shortening (%) 20 3
Sa (cm/s) 13 4
Mean PCWP (mm Hg) 8 2*
 (ms) 31 4*
PA systolic pressure (mm Hg) 23 3*
Deceleration time (ms) 213 38 1
Ar-A duration (ms) 1 10*
E/Ea 5 3*
LA volume (ml/m2) 18 6*
p  0.05 versus systolic dyssynchrony, isolated diastolic dyssynchrony, and DHF patients without
p  0.05 versus DHF patients without dyssynchrony; §p  0.05 versus control group, isolated d
ESP  end-systolic pressure; ESV  end-systolic volume; PCWP  pulmonary capillary wedge piscussion
he present study shows that systolic dyssynchrony is not
ncommon in patients with DHF, occurring in 33% of the
atients. These patients were characterized by abnormal LV
ystolic properties and had invasive and echocardiographic
ndices indicative of the most advanced stage of diastolic
ysfunction. At 58%, diastolic dyssynchrony appears to have
higher prevalence in this population. Importantly, medical
herapy results in a significant shortening of the diastolic
ntraventricular time delay, which is closely related to
and LV Relaxation and Mean PCWP
and mean wedge pressure (right)
wedge pressure.
yssynchrony
Patients
Diastolic Dyssynchrony
Systolic
hrony
20)
DHF With Isolated
Diastolic Dyssynchrony
(n  15)
DHF Without
Dyssynchrony
(n  25)
1.8§ 9.8 2.3 10 2.8
3§ 65 4 66 6
8§ 90 10 88 11
0.3§ 2.8 0.8 2.9 1.0
1§ 19 4 19 3
4.3§ 13.5 4.3 12.8 4.6
4† 22 4 20 4
7† 61 4‡ 57 4
8† 41 6 38 6
21† 190 28 200 25
13† 49 10 40 11
5† 18 4 16 6
11† 66 6‡ 56 8
chrony; †p  0.05 versus isolated diastolic dyssynchrony and DHF patients without dyssynchrony;
dyssynchrony and DHF patients without dyssynchrony.
; Sa  systolic mitral annular velocity; other abbreviations as in Table 1.elay
 (left)
pillarytslic D
DHF
c and
With
yssync
(n 
7.1
57
55
1.9
12
8.4
28
69
51
63
58
23
81
dyssyn
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January 2/9, 2007:88–96 Dyssynchrony in DHFmprovement in LV relaxation. Interestingly, patients with
HF had a rather similar prevalence of systolic and diastolic
yssynchrony: 40% and 60%, respectively.
ystolic dyssynchrony in patients with DHF. Patients
ith DHF enrolled in this study had clinical, hemodynamic,
nd echocardiographic findings typical of this disease (5).
herefore, we believe that we enrolled a well representative
ample of this patient population. In this study, patients
ith systolic dyssynchrony had consistent abnormalities in
V systolic properties which were not observed in those
ithout dyssynchrony. Specifically, LV systolic performance
as reduced, as inferred from the reduced SW (Table 2).
ikewise, LV systolic function was depressed, as inferred
rom the EF and the reduced slope of the relationship
Figure 4 Relationship Between LV Mass Index and
LV Diastolic Intraventricular Time Delay
Relationship between maximum diastolic time delay and left ventricular (LV)
mass index in patients with diastolic heart failure.
emodynamic and Echocardiographic Measurements in SHF Patienccor ing to Presen e or Absence of Systolic and Diastolic Dyssy
Table 3 Hemodynamic and Echocardiographic Measurements inAccording to Presence or Absence of Systolic and Dia
Control
(n  35)
SHF
D
Stroke work (kg · cm) 8.9 2.5* 3
Ejection fraction (%) 64 6*
Stroke work/EDV (g/cm2) 76 8*
ESP/ESV (mm Hg/ml) 2.4 0.8*
Mid-wall fractional shortening (%) 20 3*
Sa (cm/s) 13 4*
Mean PCWP (mm Hg) 8 2*
 (ms) 31 4*
PA systolic pressure (mm Hg) 23 3*
Deceleration time (ms) 213 38*
Ar-A duration (ms) 1 10*
E/Ea 5 3*
LA volume (ml/m2) 18 6*
p  0.05 versus SHF with systolic dyssynchrony, isolated diastolic dyssynchrony and SHF patie
yssynchrony; ‡p  0.05 versus SHF patients without dyssynchrony.
Abbreviations as in Tables 1 and 2.etween SW and EDV (Fig. 1). Finally, myocardial con-
ractility (Fig. 2) was abnormal. Interestingly, unlike the
ood demarcation of the 2 groups achieved by TD, there
as a wide overlap when the QRS duration was considered.
he weak correlation between the QRS duration and
ntraventricular systolic delay parallels our observations in
he group with SHF as well as other previous studies (17).
Previous studies have reported that some patients with
HF have depressed systolic function, whereas other inves-
igators did not reach similar conclusions using a more
omprehensive analysis (20). However, studies (16,20,22)
hat examined mid-wall stress-shortening relationships have
oted that a number of patients with DHF have systolic
ysfunction. Interestingly, we noted in the present study
hat 33% of the patients with DHF have systolic dyssyn-
hrony and evidence of depressed LV systolic properties. In
ddition, this subgroup of patients had worse diastolic
unction as inferred from hemodynamic and Doppler mea-
urements (Table 2). Given the multiple relations at the
yocardial and ventricular levels between LV systolic and
iastolic function, their worse diastolic function is to be
xpected.
Patients with SHF and systolic dyssynchrony have been
hown to improve their cardiac function by biventricular
acing, as assessed by invasive and noninvasive measure-
ents (2). We believe that the present study, which presents
comprehensive analysis of LV systolic and diastolic func-
ion, provides important insights into the prevalence and
equelae of systolic dyssynchrony in patients with DHF.
his information is essential when considering the potential
ole of biventricular pacing in DHF patients.
iastolic dyssynchrony in DHF patients. Diastolic dys-
ynchrony was highly prevalent in this sample (58%) and
as present without systolic dyssynchrony in 25% of the
atients. Again, the duration of the diastolic time delay was
ratifiedny
Patients Stratified
Dyssynchrony
Systolic
hrony
24)
SHF With Isolated
Diastolic Dyssynchrony
(n  12)
SHF Without
Dyssynchrony
(n  24)
2.3 4.3 2.1 3.9 1.9
5† 34 5 33 5
9† 24 14 25 15
0.3 1.6 0.6 1.5 0.5
3† 9 3 9 4
3.4† 6.3 2.8 6.6 3.1
4‡ 33 4‡ 25 5
5‡ 76 6‡ 66 11
6‡ 53 6‡ 43 5
18† 161 21 190 23
10‡ 53 13‡ 45 15
5‡ 24 5‡ 18 4
13† 73 15‡ 61 14
hout dyssynchrony; †p  0.05 versus isolated diastolic dyssynchrony and SHF patients withoutts Stchro
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Dyssynchrony in DHF January 2/9, 2007:88–96imilar to that observed in patients with SHF enrolled in
his study and previously reported by other investigators
17). There are a number of pathophysiologic mechanisms
hat can account for diastolic dyssynchrony in patients with
HF. They include systolic dyssynchrony, because seg-
ents with delayed contraction also show delayed expan-
ion. Coronary artery disease is another potential reason. In
report, coronary artery disease was associated with dia-
tolic dyssynchrony, which improved after mechanical re-
ascularization (6). However, epicardial coronary artery
isease was present in only 4 of the 35 patients with diastolic
yssynchrony in the present study. Therefore, other mech-
nisms likely play a role in the etiology of diastolic dyssyn-
hrony in this population.
The strong association between TD diastolic time delay
nd LV mass (and mass/volume ratio) raises the possibility
hat LV hypertrophy and interstitial fibrosis may be caus-
tive factors. This hypothesis, however, remains to be
ested. Finally, increased afterload appears to play an im-
ortant role. Previous animal studies showed that an acute
Figure 5 Relation Between the Change in LV Disatolic Dyssyn-
chrony Index and LV Relaxation With Medical Therapy
Relationship between the percentage change in diastolic time delay and the
corresponding percentage change in relaxation time constant  after medical
therapy for diastolic heart failure. LV  left ventricular.
Changes With Medical Therapy for DHF
Table 4 Changes With Medical Therapy for
Heart rate
Systolic/diastolic blood pressure (mm Hg)
EF (%)
Deceleration time (ms)
Pulmonary veins (Ar-A) (ms)
E/Ea ratio (average of septal and lateral)
PA systolic pressure (mm Hg)
† (ms)
Ea (average of septal and lateral) (cm/s)
*p  0.05 versus baseline; † was derived using IVRT by Doppler, and
Abbreviations as in Table 1.pncrease in LV afterload leads to increased dyssynchrony
hich was linearly correlated with  (23). In the present
tudy, a significant correlation was present between the
ecrease in LV ESP and the shortening in diastolic time
elay after medical therapy for congestive heart failure,
aising the possibility that increased afterload may have a
etrimental effect on LV relaxation, in part through in-
reased diastolic dyssynchrony.
reatment of diastolic dyssynchrony in DHF. There are
imited data on the treatment of diastolic dyssynchrony in
atients with normal EF (6–9). For patients with SHF,
iventricular pacing, which reduces the extent of systolic
yssynchrony, can result in an improvement in LV filling.
owever, the favorable effect of biventricular pacing on LV
iastolic function and dyssynchrony has been observed in
ome but not all patients (17,24), highlighting the contri-
ution of factors other than systolic dyssynchrony to the
iastolic abnormality noted in these subjects. The effects of
iventricular pacing on diastolic dyssynchrony in patients
ith DHF is speculative at this time. However, it may be
eneficial, similar to the observations in those with de-
ressed EF, to some but not all patients, given the multiple
tiologies of diastolic dyssynchrony in patients with DHF.
The correlation between diastolic dyssynchrony and LV
ass raises the possibility that regression of LV hypertrophy
nd interstitial fibrosis, which is feasible with a number of
rugs (25–29), may be of value as well. We could not
ddress this possible etiology owing to the short follow-up
f the present group.
On the other hand, it is reasonable to conclude that
eduction of systemic blood pressure, in and of itself, can
educe diastolic dyssynchrony, particularly in patients where
he QRS duration is not prolonged. Increased afterload may
ontribute to dyssynchrony through its effects on myocardial
lood flow. Increased systolic wall stress increases myocar-
ial oxygen demand, which in the presence of abnormal
ndothelial function and coronary vasculature leads to re-
ional heterogeneity in coronary blood flow and regional
unction. This mechanism is supported by previous studies
sing positron emission tomography which reported on the
Baseline After Medical Therapy
74 10 69 11
 28/86 19 125 21/68 16*
61 8 63 9
189 30 218 41*
48 5 28 8*
18 5 11 8*
46 5 34 8*
60 6 49 8*
6 3 7.5 1.9*
vasive estimation of ESP and mean PCWP.DHF
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January 2/9, 2007:88–96 Dyssynchrony in DHFatients with hypertension that was only partly determined
y the degree of LV hypertrophy (30). Therefore, antihy-
ertensive therapy can have a favorable effect on diastolic
yssynchrony that is independent of the regression of LV
ypertrophy.
tudy limitations. We examined relatively few patients
ith DHF. This was due to the study design, which aimed
t the inclusion of cases with hemodynamic measurements.
herefore, our observations need to be examined in a larger
opulation of DHF patients to arrive at a more accurate
epresentation of the prevalence of this abnormality. There
re other methods that have been used to identify systolic
yssynchrony (2). Some are based on a 6- or a 12-segment
odel. In the present study, we did not examine these
ethods and therefore can not address their application in
HF patients.
Strain measurements were not included for the assess-
ent of regional function. We believe that our conclusions
re unlikely to have changed with deformation measure-
ents for the following reasons. First, in the group with
HF and systolic dyssynchrony, evidence of depressed
ystolic properties was unambiguously and consistently ob-
erved using several indices of pump performance, systolic
unction, and myocardial function. Second, strain and strain
ate are dependent on preload and afterload and therefore
re not the gold standard to address the issue of intrinsic
yocardial contractility. Finally, the effects of tethering and
ranslation on myocardial velocities are not germane to this
tudy, because they primarily influence the accuracy of peak
elocity measurement and not the time to onset of myocar-
ial systolic or diastolic motion.
There are a number of limitations in examining the effects
f medical therapy in patients with DHF, including the fact
hat drugs were not controlled and different therapeutic
egimens were used. The number of patients receiving each
lass of medications was small and precludes drawing
eaningful comparisons with respect to the different classes
f drugs. Therefore, the effect of medications on dyssyn-
hrony reported in this study should be viewed as hypothesis
enerating, with additional studies needed to address this
uestion definitively.
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